Health Canada
- Status: approved
Neuromuscular Blocking Agents and reversing agents (Neuromuscular Blocking Agents and reversing agents) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Universitaire Ziekenhuizen KU Leuven is the originator. The local marketing authorisation holder may differ — check the official source linked above.